About this trial
This is a prospective, longitudinal, single-center observational study of data from the medical records of patients hospitalized after a characterized depressive episode and reviewed three months after hospital discharge, as part of a normally scheduled evaluation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient 18 years of age or older, having been informed of the research
Patient hospitalized at the Auzon Clinic for a characterized depressive episodé (isolated episode or recurrent depressive disorder)
Discharged from hospitalization
Considered in remission (total or partial) and with a MADRS score < 20
Disqualifiers
Patient hospitalized for < 15 days
Patient with bipolar depression
Patient with a psychotic disorder
Patient using narcotics with a "moderate to severe" severity
Trial population
Patients hospitalized for a characterized depressive episode and considered in remission at discharge.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Depressive episode relapse
Relapse within three months of hospitalization
Secondary outcomes
Psychic symptoms of depression
The Multidimensional Self-Questionnaire for Depression Assessment DD4 (Ducher's Depression Scale) is presented in the form of four modules. Each module consists of 15 identical questions (I feel sad, I suffer morally...). The formulation of the questions allows for evaluation from 0 to 4 in different dimensions: DD4 A: Global Evaluation (not at all true, a little true, rather true, very true, completely true) DD4 F: Frequency Evaluation (never, sometimes, often, very often, permanently) DD4 I: Intensity Evaluation (not at all, slightly, fairly, a lot, enormously) DD4 M: Maximal Evaluation (uses the criteria of the global evaluation, but during the moments when the patient feels the saddest or most depressed). An additional question asks about the frequency of these periods (never, sometimes, often, very often, permanently).
Depressive symptomology
Measured with the Montgomery and Asberg (MADRS) scale
Sponsors and contacts
Click on the lead sponsor to view all of their trials.